Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Hepatitis 1 Colitis 1

Interventions

pembrolizumab 299 Carboplatin 229 Cisplatin 159 Gemcitabine 152 Paclitaxel 151 Pemetrexed 121 Bevacizumab 121 Docetaxel 106 Oxaliplatin 82 durvalumab 81 Nivolumab 81 Dexamethasone 80 atezolizumab 79 Fluorouracil 79 Cyclophosphamide 77 130-nm albumin-bound paclitaxel 73 Fulvestrant 72 Capecitabine 67 Injections 66 Cetuximab 64 Leucovorin 63 Rituximab 56 fludarabine 51 Lenalidomide 50 venetoclax 46 Prednisone 45 Letrozole 42 Irinotecan 42 enzalutamide 41 tislelizumab 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × vedolizumab × 90 days × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡